Tandem's Predictive Technologies: Pediatric Pivotal Trial of Control-IQ Technology in Children with Type 1 Diabetes

Join Betsy Dokken, NP, PhD, Director of Clinical Affairs at Tandem Diabetes Care, to learn more about the results from the pediatric pivotal trial (DCLP5) data published in the New England Journal of Medicine (NEJM): A Randomized Control of Closed-Loop Control in Children with Type 1 Diabetes. This webinar will cover the study results of the pivotal trial and a pediatric case study. The presentation will be followed by a speaker Q&A.

Originally broadcast on February 16, 2021, Betsy Dokken, NP, PhD, Director of Clinical Affairs at Tandem Diabetes Care, presented the results from the pediatric pivotal trial (DCLP5) data published in the New England Journal of Medicine (NEJM): A Randomized Control of Closed-Loop Control in Children with Type 1 Diabetes.

This webinar covered the study results of the pivotal trial and a pediatric case study. The presentation was followed by a speaker Q&A.

Watch the webinar

Leave a comment

Order by

Newest on top Oldest on top
Load more comments
Comment by from

* Tandem Diabetes Care will have an exhibit table at each event, but Tandem is not the event organizer and does not have control of the information shared outside of its exhibit space.